ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases
Gespeichert in:
| Veröffentlicht in: | Journal of Nuclear Medicine 2020-02, Vol.61 (2), p.305-305 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 305 |
|---|---|
| container_issue | 2 |
| container_start_page | 305 |
| container_title | Journal of Nuclear Medicine |
| container_volume | 61 |
| creator | van de Stadt, Eveline A Yaqub, Maqsood Bahce, Idris Hendrikse, N H |
| description | |
| doi_str_mv | 10.2967/jnumed.119.235705 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2301443202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2301443202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-8aea85b1fbdd58d0ace953add96034e255b14cf951af8be71b211183326656693</originalsourceid><addsrcrecordid>eNpdkc9O3DAQxq2Kqiy0D9BLZYkLl2w9duw43CDlz0q0PQDnyEkmxavECbZTidfgifFq4YI00jfS_L7RaD5CvgNb81IVP7duGbFbA5RrLmTB5CeyAilkJpUqDsiKgYJMSiYPyVEIW8aY0lp_IYcCpFaMFSvycn5RXfOMGtfR1F4A3bhH29hoJ0cfgnX_6N0yexMf0ZsZl2hb-msKGOjU00s_TNE625zRakjamoFuxnlIzc4fqHU0Gem9RxNHdHFnqpL6BP5B_39aAr17DhFH-hujCakwfCWfezME_Pamx-Th6vK-uslu_15vqvPbrBU8j5k2aLRsoG-6TuqOmRZLKUzXlYqJHLlMs7ztSwmm1w0W0HAA0EJwpdJ_SnFMTvd7Zz89LRhiPdrQ4jAYh-mwmgsGeS444wk9-YBup8W7dF2iZC4AWMkSBXuq9VMIHvt69nY0_rkGVu8Cq_eB1Smweh9Y8vx427w0u9G74z0h8QqxVZK0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2354311090</pqid></control><display><type>article</type><title>ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>van de Stadt, Eveline A ; Yaqub, Maqsood ; Bahce, Idris ; Hendrikse, N H</creator><creatorcontrib>van de Stadt, Eveline A ; Yaqub, Maqsood ; Bahce, Idris ; Hendrikse, N H</creatorcontrib><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>EISSN: 2159-662X</identifier><identifier>DOI: 10.2967/jnumed.119.235705</identifier><identifier>PMID: 31586007</identifier><language>eng</language><publisher>United States: Society of Nuclear Medicine</publisher><subject>Central nervous system ; Metastases</subject><ispartof>Journal of Nuclear Medicine, 2020-02, Vol.61 (2), p.305-305</ispartof><rights>Copyright Society of Nuclear Medicine Feb 1, 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c324t-8aea85b1fbdd58d0ace953add96034e255b14cf951af8be71b211183326656693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31586007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van de Stadt, Eveline A</creatorcontrib><creatorcontrib>Yaqub, Maqsood</creatorcontrib><creatorcontrib>Bahce, Idris</creatorcontrib><creatorcontrib>Hendrikse, N H</creatorcontrib><title>ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases</title><title>Journal of Nuclear Medicine</title><addtitle>J Nucl Med</addtitle><subject>Central nervous system</subject><subject>Metastases</subject><issn>0161-5505</issn><issn>1535-5667</issn><issn>2159-662X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkc9O3DAQxq2Kqiy0D9BLZYkLl2w9duw43CDlz0q0PQDnyEkmxavECbZTidfgifFq4YI00jfS_L7RaD5CvgNb81IVP7duGbFbA5RrLmTB5CeyAilkJpUqDsiKgYJMSiYPyVEIW8aY0lp_IYcCpFaMFSvycn5RXfOMGtfR1F4A3bhH29hoJ0cfgnX_6N0yexMf0ZsZl2hb-msKGOjU00s_TNE625zRakjamoFuxnlIzc4fqHU0Gem9RxNHdHFnqpL6BP5B_39aAr17DhFH-hujCakwfCWfezME_Pamx-Th6vK-uslu_15vqvPbrBU8j5k2aLRsoG-6TuqOmRZLKUzXlYqJHLlMs7ztSwmm1w0W0HAA0EJwpdJ_SnFMTvd7Zz89LRhiPdrQ4jAYh-mwmgsGeS444wk9-YBup8W7dF2iZC4AWMkSBXuq9VMIHvt69nY0_rkGVu8Cq_eB1Smweh9Y8vx427w0u9G74z0h8QqxVZK0</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>van de Stadt, Eveline A</creator><creator>Yaqub, Maqsood</creator><creator>Bahce, Idris</creator><creator>Hendrikse, N H</creator><general>Society of Nuclear Medicine</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>4T-</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>202002</creationdate><title>ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases</title><author>van de Stadt, Eveline A ; Yaqub, Maqsood ; Bahce, Idris ; Hendrikse, N H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-8aea85b1fbdd58d0ace953add96034e255b14cf951af8be71b211183326656693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Central nervous system</topic><topic>Metastases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van de Stadt, Eveline A</creatorcontrib><creatorcontrib>Yaqub, Maqsood</creatorcontrib><creatorcontrib>Bahce, Idris</creatorcontrib><creatorcontrib>Hendrikse, N H</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Docstoc</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Nuclear Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van de Stadt, Eveline A</au><au>Yaqub, Maqsood</au><au>Bahce, Idris</au><au>Hendrikse, N H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases</atitle><jtitle>Journal of Nuclear Medicine</jtitle><addtitle>J Nucl Med</addtitle><date>2020-02</date><risdate>2020</risdate><volume>61</volume><issue>2</issue><spage>305</spage><epage>305</epage><pages>305-305</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><eissn>2159-662X</eissn><cop>United States</cop><pub>Society of Nuclear Medicine</pub><pmid>31586007</pmid><doi>10.2967/jnumed.119.235705</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0161-5505 |
| ispartof | Journal of Nuclear Medicine, 2020-02, Vol.61 (2), p.305-305 |
| issn | 0161-5505 1535-5667 2159-662X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2301443202 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Central nervous system Metastases |
| title | ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABCG2-%20and%20ABCB1%20Inhibition%20Using%20Supratherapeutic%20Doses%20of%20Erlotinib:%20Clinical%20Implications%20in%20the%20Treatment%20of%20Central%20Nervous%20System%20Metastases&rft.jtitle=Journal%20of%20Nuclear%20Medicine&rft.au=van%20de%20Stadt,%20Eveline%20A&rft.date=2020-02&rft.volume=61&rft.issue=2&rft.spage=305&rft.epage=305&rft.pages=305-305&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/10.2967/jnumed.119.235705&rft_dat=%3Cproquest_cross%3E2301443202%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2354311090&rft_id=info:pmid/31586007&rfr_iscdi=true |